| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 08/08/2002 | WO2002060317A2 Compositions and methods for the therapy and diagnosis of pancreatic cancer |
| 08/08/2002 | WO2002060279A1 $g(a)-lactalbumin as prebiotic agent |
| 08/08/2002 | WO2002043746A3 Compounds with the biological activity of vasoactive intestinal peptide for the treatment of pulmonary and arteriolar hypertension |
| 08/08/2002 | WO2002042441A3 VON WILLEBRAND FACTOR (vWF) CLEAVING PROTEASE POLYPEPTIDE, NUCLEIC ACID ENCODING THE POLYPEPTIDE AND USE OF POLYPEPTIDE |
| 08/08/2002 | WO2002040516A3 Helicobacter cysteine rich protein a (hcpa) and uses thereof |
| 08/08/2002 | WO2002038597A3 Genomic fragment of streptococcus suis and clinical uses thereof |
| 08/08/2002 | WO2002030887A3 Protein having thrombolytic activities extracted from natural product |
| 08/08/2002 | WO2002030455A3 Agents for the treatment of viral infections |
| 08/08/2002 | WO2002028165A3 Compositions and methods of using capsid protein from flaviviruses and pestiviruses |
| 08/08/2002 | WO2002022175A3 Method and composition for treating tumors by selective induction of apoptosis |
| 08/08/2002 | WO2002022161A3 The diagnosis, prevention, and/or treatment of atherosclerosis and underlying and/or related diseases |
| 08/08/2002 | WO2002020762A3 Tnf receptor-like molecules and uses thereof |
| 08/08/2002 | WO2002018582A3 62112, a novel human dehydrogenase and uses thereof |
| 08/08/2002 | WO2002018556A3 8797, a human galactosyltransferase and uses thereof |
| 08/08/2002 | WO2002018432A3 Protein extracted from the intestines of vertebrates, which absorbs cholesterol, and the use of this protein for identifying inhibitors of intestinal cholesterol transport |
| 08/08/2002 | WO2002015664A3 Methods of preventing or treating west nile virus and other infections |
| 08/08/2002 | WO2002014366A3 Genes involved in immune related responses observed with asthma |
| 08/08/2002 | WO2002014347A3 Method for producing peptide salts, their use, and pharmaceutical preparations containing these peptide salts |
| 08/08/2002 | WO2002011747A3 Transglutaminase for inhibiting angiogenesis |
| 08/08/2002 | WO2002006318A3 Methods and compositions for stabilizing microtubules and intermediate filaments in striated muscle cells |
| 08/08/2002 | WO2002000853A3 Regulation of human caspase-1-like protease |
| 08/08/2002 | WO2002000840A3 Human lyases |
| 08/08/2002 | WO2002000695A3 Peptides for the preparation of vaccines against bordetella pertussis and bordetella parapertussis |
| 08/08/2002 | WO2002000170A3 Targeted delivery of cytotoxic drugs a) to activated lymphocytes in patients with transplanted organs, b) as radiosensitizers to cancer cells in patients undergoing radiation therapy, and c) in vitamin-binding proteins as drug carriers in the diagnosis and treatment of cancer |
| 08/08/2002 | WO2001098522A3 Positively-charged peptide nucleic acid analogs with improved properties |
| 08/08/2002 | WO2001098455A3 Method for preparing a physiologically active il-18 polypeptide |
| 08/08/2002 | WO2001096546A3 Protein phosphatases |
| 08/08/2002 | WO2001096393A3 Nucleotide and amino acid sequences of oocyte factors for altering ovarian follicular growth in vivo or in vitro |
| 08/08/2002 | WO2001096379A3 Immunization of dairy cattle with chimeric gapc protein against streptococcus infection |
| 08/08/2002 | WO2001092522A3 Human fgf-20 nucleic acids and polypeptides |
| 08/08/2002 | WO2001092306A3 Therapeutic compounds for ovarian cancer |
| 08/08/2002 | WO2001092295A3 Ligands for cd21 and compositions thereof for modulating immune responses |
| 08/08/2002 | WO2001091814A3 Polyubiquitin based hydrogel and uses thereof |
| 08/08/2002 | WO2001090361A3 Modulation of inflammation by protease-treated mcp-3 chemokine |
| 08/08/2002 | WO2001090330A3 AMINOACYL tRNA SYNTHETASES |
| 08/08/2002 | WO2001090309A3 Peptides that stimulate mycobacterial growth |
| 08/08/2002 | WO2001087935A3 Methods of modulating angiogenesis by regulating the expression of pituitary tumor transforming gene (pttg) |
| 08/08/2002 | WO2001085926A3 Nucleotide sequences involved in increasing or decreasing mammalian ovulation rate |
| 08/08/2002 | WO2001085784A9 POLYNUCLEOTIDES ENCODING FOR POLYMORPHIC ISOFORMS OF THE PTHrP PROTEIN, THE ENCODED PROTEINS AND THEIR THERAPEUTIC APPLICATIONS THEREOF |
| 08/08/2002 | WO2001085664A3 Compounds and methods for regulating bacterial growth and pathogenesis |
| 08/08/2002 | WO2001081585A3 A thymus expressed human cytochrome p450 (p450tec) |
| 08/08/2002 | WO2001079274B1 Tuberculosis antigens and methods of use thereof |
| 08/08/2002 | WO2001070941A3 An infective endogenous retrovirus in association with demyelinating diseases e.g. multiple sclerosis |
| 08/08/2002 | WO2001068117A3 Immunostimulatory polynucleotide sequences for use in preventing and treating viral infections |
| 08/08/2002 | WO2001064905A3 2504, 15977, and 14760, novel protein kinase family members and uses therefor |
| 08/08/2002 | WO2001061001A9 Novel, central nervous protein, that modulates k+ flows |
| 08/08/2002 | WO2001059152A9 Polymorphisms in the human cyp2b6 gene and their use in diagnostic and therapeutic applications |
| 08/08/2002 | WO2001051641A9 Irak-4: compositions and methods of use |
| 08/08/2002 | WO2001051523A3 Anti-angiogenic proteins and fragments and methods of use thereof |
| 08/08/2002 | WO2001051073A9 The parenteral use of bacterial phage associated lysing enzymes for the therapeutic treatment of bacterial infections |
| 08/08/2002 | WO2001036419A9 Use of 9-substituted hypoxanthine derivatives to stimulate regeneration of nervous tissue |
| 08/08/2002 | WO2001034802A9 Compositions and methods for the therapy and diagnosis of prostate cancer |
| 08/08/2002 | WO2001032925A9 Modulation of neuroendocrine differentiation by protein 25.1 |
| 08/08/2002 | WO2001030968A3 Glutamate transporter associated proteins and methods of use thereof |
| 08/08/2002 | WO2001013714A3 Prostatic cell line and animal model of a prostatic tumor |
| 08/08/2002 | WO2001009328A9 15571, a novel gpcr-like molecule of the secretin-like family and uses thereof |
| 08/08/2002 | WO2001009325A9 Human p53 mutations and a genetic system in yeast for functional indentification of human p53 mutations |
| 08/08/2002 | WO2001003719A9 Combination therapy for conditions leading to bone loss |
| 08/08/2002 | WO2000074736A9 Formulations comprising dehydrated particles of pharmaceutical agents and process for preparing the same |
| 08/08/2002 | WO2000055314A9 Inhibitors of endothelin-1 synthesis |
| 08/08/2002 | US20020108144 Anti-microbial protein |
| 08/08/2002 | US20020108133 Isolated human phosphatase proteins, nucleic acid molecules encoding human phosphatase proteins, and uses thereof |
| 08/08/2002 | US20020107869 Novel implant and novel vector for the treatment of acquired diseases |
| 08/08/2002 | US20020107505 Modification of polypeptide drugs to increase electrotransport flux |
| 08/08/2002 | US20020107429 Compositions, devices, methods, and kits for induction of adhesions |
| 08/08/2002 | US20020107386 Methods and compositions relating to bone-derived growth factor-like polypeptides |
| 08/08/2002 | US20020107385 Human breast tumor-specific proteins |
| 08/08/2002 | US20020107382 Nnucleotide sequences which code enzyme inhibitor for use in human therapeutics and diagnostics, cosmetics, nutrients and animal feeds |
| 08/08/2002 | US20020107381 Nucleotide sequences coding enzymatic polypeptides for use in the treatment and prevention of diabetes, dietetics, sex disorders and infection |
| 08/08/2002 | US20020107380 Nucleotide sequences coding polypeptide fpr use in the human therapeutics, pharmacology, foods and animal feeds |
| 08/08/2002 | US20020107376 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of liver disorders and cancer |
| 08/08/2002 | US20020107375 Novel human lipocalin homologs and polynucleotides encoding the same |
| 08/08/2002 | US20020107374 Coding sequence for protein phosphatase methylesterase, recombinant DNA molecules and methods |
| 08/08/2002 | US20020107373 49937, 49931, and 49933, novel human transporter family members and uses thereof |
| 08/08/2002 | US20020107372 Nucleotide sequences coding membrane protein for use in the treatment of inflammation,lung defects and viral diseases |
| 08/08/2002 | US20020107370 Protein for use in the treatment of lzheimer's, parkinson's, amyotrophic lateral sclerosis, multiple sclerosis, retinopathy, brain, blood, myocardium, stroke, reperfusion injury and liver disorders |
| 08/08/2002 | US20020107368 Helicobacter proteins, gene sequences and uses thereof |
| 08/08/2002 | US20020107366 Polypeptide for use in the treatment of mammalian viral diseases |
| 08/08/2002 | US20020107365 Ligands for flt3 receptors |
| 08/08/2002 | US20020107364 Compositions and methods for regulating bacterial pathogenesis |
| 08/08/2002 | US20020107363 B7-Like molecules and uses thereof |
| 08/08/2002 | US20020107361 Novel metalloproteases having thrombospondin domains and nucleic acid compositions encoding the same |
| 08/08/2002 | US20020107360 Hepatitis E virus antigens and uses therefor |
| 08/08/2002 | US20020107359 Protein model for use in drug design in human therapeutics |
| 08/08/2002 | US20020107292 Primary composition comprising a lipophilic bioactive compound |
| 08/08/2002 | US20020107247 Method of treating sexual disturbances |
| 08/08/2002 | US20020107241 N-heterocyclic derivatives useful for treating or preventing neuronal damage associated with neurological disease |
| 08/08/2002 | US20020107240 N-substituted glycine derivatives useful for treating or preventing neuronal damage associated with neurological disease |
| 08/08/2002 | US20020107239 Cyclized amide derivatives |
| 08/08/2002 | US20020107236 Methods of treating sexual dysfunction associated with hypertension |
| 08/08/2002 | US20020107226 Assays and reagents for identifying anti-fungal agnets, amd uses related thereto |
| 08/08/2002 | US20020107225 Use of nucleoside analogues (cytosine or 5-fluorocytosine containing compound) useful for acute or chronic myelogenous leukemia |
| 08/08/2002 | US20020107221 Nucleosides with anti-hepatitis B virus activity |
| 08/08/2002 | US20020107218 Using inhibitors such as antisense nucleic acids |
| 08/08/2002 | US20020107217 galK |
| 08/08/2002 | US20020107216 Antisense oligonucleotides complementary to Integrin-linked kinase (ILK) |
| 08/08/2002 | US20020107213 Gene therapy of alzheimer's disease by delivery of an encoded apoliprotein E |
| 08/08/2002 | US20020107212 Methods of reducing papillomavirus infection using immunomodulatory polynucleotide sequences |
| 08/08/2002 | US20020107211 Ob polypeptides; treating obesity; antagonists thereof to increase weight |
| 08/08/2002 | US20020107210 Compositions and methods for the treatment of autoimmune diabetes |